OFI Invest Asset Management Purchases 112 Shares of Humana Inc. $HUM

OFI Invest Asset Management grew its position in shares of Humana Inc. (NYSE:HUM) by 40.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 390 shares of the insurance provider’s stock after buying an additional 112 shares during the period. OFI Invest Asset Management’s holdings in Humana were worth $95,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in HUM. Cary Street Partners Investment Advisory LLC increased its position in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after buying an additional 46 shares during the period. Garde Capital Inc. bought a new position in Humana during the 1st quarter worth $36,000. Zions Bancorporation National Association UT bought a new position in Humana during the 1st quarter worth $37,000. Ransom Advisory Ltd bought a new position in Humana during the 1st quarter worth $66,000. Finally, Rakuten Securities Inc. grew its holdings in shares of Humana by 50.0% during the 1st quarter. Rakuten Securities Inc. now owns 300 shares of the insurance provider’s stock worth $79,000 after purchasing an additional 100 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of several analyst reports. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a report on Wednesday, October 8th. Wells Fargo & Company raised their price objective on Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Evercore ISI began coverage on Humana in a research note on Monday, September 22nd. They issued an “in-line” rating and a $295.00 price objective on the stock. Finally, Royal Bank Of Canada raised their price objective on Humana from $283.00 to $322.00 and gave the company an “outperform” rating in a research note on Thursday, August 21st. Eight research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $298.83.

Humana Stock Performance

Shares of HUM stock opened at $270.84 on Tuesday. The business’s 50-day moving average price is $279.92 and its 200-day moving average price is $258.09. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $315.35. The firm has a market capitalization of $32.57 billion, a price-to-earnings ratio of 20.79, a PEG ratio of 1.64 and a beta of 0.42. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same period in the previous year, the business posted $6.96 earnings per share. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana’s dividend payout ratio (DPR) is presently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.